Continuing Education as Part of the Ockham Method

N. America: 919-462-8867

		Clinical Development
		Consulting
		Trial Management
		Electronic Data Capture

Home >> Ockham Method >> Continuing Education

Continuing Education is a Key Component of the Ockham Method

In order to provide the industry-leading level of quality and project management our Sponsors have come to rely upon, Ockham recognizes that ongoing education and training is essential for its personnel. In addition to traditional education, Ockham also sponsors regular, weekly lunch and learn training programs. These required tutorial seminars are prepared and presented by both in-house and external academic and industry experts in the topic or field covered. Some programs are project-focused, while others have the broader goal of general staff development.

Topic Group: Therapeutic Area
Raynaud’s Phenomenon: Characteristics and Treatment
Understanding Cancer
Ovarian Cancer
Treatment of Solid Tumors
Treatment of Solid Tumors (part 3)
Glioblastoma
Glioblastoma: Introduction to Brain Tumors
Glioblastoma: Classification and Staging
Glioblastoma: Treatment
Psychiatry: Diagnosis and DSM IV
Psychiatric Tests & Instruments
Bipolar Illness
Treatment of Bipolar Illness
Dementia: Introduction
Domains of Memory and Cognition
Leukemia 1: ALL, AML, MDS
Leukemia 2: CML, CLL, CMLB
Acute Myeloid Leukemia and Myelodysplastic Syndrome
Ulcerative Colitis I

Topic Group: Regulatory
Human Participant Protections Education for Research Teams
Responsibilities of Sponsors and Investigators (GCP and CFR)
Regulatory Topics: HIPAA
Institutional Review Boards (21 CFR Part 56, ICH)
Drug Safety: SOP/WPD Overview
Informed Consent Process
Drug Development Life-Cycle
Regulatory Aspects of Device Trials
CFR Part 11
Regulatory Reporting of SAEs
ICH GCP: Investigators

Topic Group: Safety Monitoring & Regulatory
Identifying SAEs and the CFR

Topic Group: Safety Monitoring
Understanding and Monitoring Lab Results
Understanding and Monitoring Lab Results

Topic Group: General/Regulatory
What is Validation? 21 CFR Part 11

Topic Group: General Clinical
RECIST: Response Evaluation Criteria in Solid Tumors
Hypertension: Diagnosis and Treatment
Hypertension: Diagnosis and Treatment (part 2)

Topic Group: Staff Development
Do’s and Don’ts of BD Presentations
Information Technology and Filing
Introduction to Biostatistics
Data Management: SOP/WPD Overview
Influenza: Introduction
Insomnia: Differential Diagnosis and Management
Atherosclerosis
Coding of Adverse Events
Biotechnology Development: Overview of Regulatory Milestones and Other Considerations
CTD: Overview and General Considerations
Training Files

Topic Group: Clinical
ICH GCP: Principles & IRBs
Safety Data Reconciliation
Test Article Accountability for IP
Clinical Study Documentation
The CSR
Research Misconduct
What is Source Documentation?
The CRO-Site Relationship
Data Listings Review: AEs, Medical History
Generic Drug Approval Process
Vital Signs
ECG Interpretation for the Non-Clinician
Audits, Compliance, and Internal Quality
Glioblastoma: Diagnosis, Classification, Staging
Auditing and Ethics 101
Informed Consent
Sponsor Responsibilities and Safety Management

Topic Group: Statistics
Current Trends in Analytics

Topic Group: Policies/Procedures
Business-Related Travel & Reimbursement
Drug Safety: SOPs
Disaster Recovery
Clinical SOPs
Global SOPs

Topic Group: Project Specific
Atherosclerosis: Introduction
Alzheimer’s Dementia Protocol Training
Chronic Obstructive Pulmonary Disorder (COPD)
Mild Cognitive Impairment Protocol Training

Topic Group: Multidisciplinary
Protocol Violations, Deviations, & Waivers: Who is Your Customer?

Back to the Ockham Method

Review “Critical Success Factors”